The Structure of Phosphorylated GSK-3β Complexed with a Peptide, FRATtide, that Inhibits β-Catenin Phosphorylation

This publication has 45 references indexed in Scilit:

• GSK‐3 inhibition by adenoviral FRAT1 overexpression is neuroprotective and induces Tau dephosphorylation and β‐catenin stabilisation without elevation of glycogen synthase activity
  FEBS Letters, 2001
• Wnt Signaling in Oncogenesis and Embryogenesis--a Look Outside the Nucleus
  Science, 2000
• Mechanism and function of signal transduction by the Wnt/β-catenin and Wnt/Ca2+ pathways
  Oncogene, 1999
• A GSK3‐binding peptide from FRAT1 selectively inhibits the GSK3‐catalysed phosphorylation of Axin and β‐catenin
  FEBS Letters, 1999
• The Croonian Lecture 1998. Identification of a protein kinase cascade of major importance in insulin signal transduction
  Philosophical Transactions Of The Royal Society B-Biological Sciences, 1999
• Downregulation of β-catenin by human Axin and its association with the APC tumor suppressor, β-catenin and GSK3β
  Published by Elsevier ,1998
• Regulation of eukaryotic initiation factor eIF2B: glycogen synthase kinase‐3 phosphorylates a conserved serine which undergoes dephosphorylation in response to insulin
  FEBS Letters, 1998
• Activation Mechanism of the MAP Kinase ERK2 by Dual Phosphorylation
  Cell, 1997
• Tyrosine dephosphorylation of glycogen synthase kinase‐3 is involved in its extracellular signal‐dependent inactivation
  FEBS Letters, 1996
• Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
  Nature, 1995